MicroRNAs as biomarkers for major depression: a role for let-7b and let-7c.
Gururajan A, Naughton ME, Scott KA, O'Connor RM, Moloney G, Clarke G, Dowling J, Walsh A, Ismail F, Shorten G, Scott L, McLoughlin DM, Cryan JF, Dinan TG.
Transl Psychiatry/2016/Aug 2;6(8):e862. PMID: 27483380US National Library of Medicine National Institutes of Health
Anodal transcranial direct current stimulation of the left dorsolateral prefrontal cortex enhances emotion recognition in depressed patients and controls.
Brennan S, McLoughlin DM, O'Connell R, Bogue J, O'Connor S, McHugh C, Glennon M
J Clin Exp Neuropsychol/2016/Sep 23:1-12. [Epub ahead of print]. PMID: 27662113US National Library of Medicine National Institutes of Health
Ketamine for depression relapse prevention following electroconvulsive therapy: protocol for a randomised pilot trial (the KEEP-WELL trial)
Martha Finnegan M, Ryan K, Shanahan E, Harkin A, Daly L, McLoughlin DM
Pilot and Feasibility Studies/2016/2:38. DOI 10.1186/s40814-016-0080-0
MicroRNAs as biomarkers for major depression: A role for let-7b and let-7c
Cryan J, Gururajan A, Naughton M, Scott K, Moloney G, Clarke G, Dowling J, Walsh A, Ismail MF, Shorten G, Scott L, McLoughlin D, Dinan T
Ten-year outcomes in first episode psychotic major depression patients compared with schizophrenia and bipolar patients
Heslin M, Lappin JM, Donoghue K, Lomas B, Reininghaus U, Onyejiaka A, Croudace T, Jones PB, Murray RM, Fearon P, Doody GA, Dazzan P, Craiga TJ, Morgan C
Alteration of Immune Markers in a group of Melancholic Depressed patients and their Response to Electroconvulsive Therapy
Journal of Affective Disorders/2016